ArticleNature communications2021

Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy.

Riyao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.